| Prognostic factors for patients with diffuse large B cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation in the positron emission … P Armand, S Welch, HT Kim, AS LaCasce, ED Jacobsen, MS Davids, ... British journal of haematology 160 (5), 608-617, 2013 | 88 | 2013 |
| Risk factors for invasive fungal disease after allogeneic hematopoietic stem cell transplantation: a single center experience AK Omer, PD Ziakas, T Anagnostou, E Coughlin, T Kourkoumpetis, ... Biology of Blood and Marrow Transplantation 19 (8), 1190-1196, 2013 | 87 | 2013 |
| Outcomes in patients age 70 or older undergoing allogeneic hematopoietic stem cell transplantation for hematologic malignancies AM Brunner, HT Kim, E Coughlin, EP Alyea III, P Armand, KK Ballen, ... Biology of Blood and Marrow Transplantation 19 (9), 1374-1380, 2013 | 86 | 2013 |
| Expression of CD30 in patients with acute graft-versus-host disease YB Chen, S McDonough, R Hasserjian, H Chen, E Coughlin, C Illiano, ... Blood, The Journal of the American Society of Hematology 120 (3), 691-696, 2012 | 63 | 2012 |
| Busulfan dose intensity and outcomes in reduced-intensity allogeneic peripheral blood stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemia YB Chen, E Coughlin, KF Kennedy, EP Alyea, P Armand, EC Attar, ... Biology of Blood and Marrow Transplantation 19 (6), 981-987, 2013 | 54 | 2013 |
| Phase I study of urate oxidase in the reduction of acute graft-versus-host disease after myeloablative allogeneic stem cell transplantation AC Yeh, AM Brunner, TR Spitzer, YB Chen, E Coughlin, S McAfee, ... Biology of Blood and Marrow Transplantation 20 (5), 730-734, 2014 | 17 | 2014 |
| Impact of umbilical cord unit banking conditions on clinical outcomes in double cord transplant recipients S Nikiforow, S Li, E Coughlin, E Breault, D Liney, G Kao, K Snow, ... Blood 122 (21), 695, 2013 | 2 | 2013 |
| Phase II Trial of High-Dose Rituximab with Thiotepa/Busulfan/Cyclophosphamide (TBC) Autologous Stem Cell Transplantation for Patients with CNS Involvement by Non-Hodgkin Lymphoma YB Chen, T Batchelor, E Hochberg, M Brezina, E Coughlin, SA Jones, ... Biology of Blood and Marrow Transplantation 19 (2), S129-S130, 2013 | 1 | 2013 |
| Outcomes of patients older than age 70 undergoing allogeneic hematopoietic stem cell transplantation for hematologic malignancies AM Brunner, YB Chen, H Kim, E Coughlin, EP Alyea, P Armand, K Ballen, ... Biology of Blood and Marrow Transplantation 19 (2), S114, 2013 | 1 | 2013 |
| Improved Overall Survival in Patients with Grade III and IV Acute Graft-Versus-Host Disease A El-Jawahri, S Li, E Coughlin, VT Ho, EP Alyea, P Armand, KK Ballen, ... Biology of Blood and Marrow Transplantation 20 (2), S265, 2014 | | 2014 |
| Phase II Trial of Reduced Intensity Busulfan/Clofarabine Conditioning with Allogeneic Hematopoietic Stem Cell Transplantation for Patients with AML, MDS, and ALL YB Chen, S Li, C Del Rio, E Coughlin, KK Ballen, CS Cutler, BR Dey, ... Biology of Blood and Marrow Transplantation 20 (2), S217-S218, 2014 | | 2014 |
| Busulfan Does Intensity and Outcomes in Reduced Intensity Allogeneic Stem Cell Transplantation for MDS/AML YB Chen, E Coughlin, C Cutler, K Kennedy, EP Alyea, P Armand, EC Attar, ... Biology of Blood and Marrow Transplantation 19 (2), S114-S115, 2013 | | 2013 |
| Lower Uric Acid Level At the Time of Allogeneic Hematopoietic Cell Transplantation (HCT) Is Protective Against Acute Graft-Vs-Host-Disease AC Yeh, AM Brunner, TR Spitzer, YB Chen, E Coughlin, SL McAfee, ... Biology of Blood and Marrow Transplantation 19 (2), S143-S144, 2013 | | 2013 |
| Prognostic Factors for Patients with Diffuse Large B Cell Lymphoma and Transformed Indolent Lymphoma Undergoing Autologous Stem Cell Transplantation in the PET Era S Welch, P Armand, HT Kim, AS LaCasce, E Jacobsen, MS Davids, ... Blood 120 (21), 1980, 2012 | | 2012 |
| Urate Oxidase (Rasburicase) to Inhibit Graft Versus Host Disease (GVHD) After Myeloablative HLA-Matched Allogeneic Hematopoietic Cell Transplantation (HCT). AM Brunner, TR Spitzer, YBA Chen, E Coughlin, SL McAfee, KK Ballen, ... Blood 120 (21), 3063, 2012 | | 2012 |
| Long-Term Outcomes of Myeloablative Hematopoietic Cell Transplantation Using Total Body Irradiation Prior to Systemic Therapy CL Toretta, A Niemierko, E Coughlin, SL McAfee, BR Dey, KK Ballen, ... Blood 120 (21), 4552, 2012 | | 2012 |
| Expression of CD30 Is Increased on CD8+ T-Cells in Patients with Acute Graft-Vs-Host Disease YB Chen, S McDonough, H Chen, J Kennedy, E Coughlin, M Jagasia, ... Biology of Blood and Marrow Transplantation 18 (2), S210, 2012 | | 2012 |
